Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

SHPHNasdaqHealthcareDrug Manufacturers - Specialty & Generic
$0.45 -0.04 (-7.82%)

Company Overview

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Price Chart

Historical Trend (Absolute Values)
SHPH Price
05/2005/2906/05

Financial Metrics

Market Capitalization$2.66M
P/E Ratio45.4
Earnings Per Share (EPS)$0
Dividend Yield
Beta (Volatility)1.22
Price to Book (P/B)0.4025
52-Week Range$0.38 - $6.20

LAST SCRARED: June 6, 2026

Compare SHPH

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.